XML 28 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Intangible Assets, Net
 9 Months Ended
Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net GOODWILL AND INTANGIBLE ASSETS, NET
Goodwill
As of September 30, 2020, we had no accumulated impairment losses related to goodwill.

Intangible Assets
As of September 30, 2020 and December 31, 2019, our intangible assets consisted of the following (in thousands):
 September 30, 2020December 31, 2019
 AccumulatedCumulative  AccumulatedCumulative 
 CostAmortizationImpairmentsNetCostAmortizationImpairmentsNet
Amortizable intangible assets:      
Makena auto-injector developed technology$79,100 $21,701 $55,426 $1,973 $79,100 $15,782 $55,426 $7,892 
Intrarosa developed technology— — — — 77,655 16,798 56,881 3,976 
Vyleesi developed technology— — — — 60,000 9,264 38,984 11,752 
Total intangible assets$79,100 $21,701 $55,426 $1,973 $216,755 $41,844 $151,291 $23,620 


In May 2020, we sold all of our rights to Intrarosa and accordingly, wrote off the related developed technology intangible asset. In July 2020, we completed the divestiture of Vyleesi and accordingly, wrote off the related developed technology intangible asset, which was fully amortized as of June 30, 2020.

As of September 30, 2020, the weighted average remaining amortization period for our finite-lived intangible assets was less than one year. Total amortization expense for the nine months ended September 30, 2020 and 2019 was $20.8 million and $12.1 million, respectively. Amortization expense is recorded in cost of product sales on our condensed consolidated statements of operations. We expect our finite-lived intangible assets to be fully amortized in 2020.